sábado, 25 de marzo de 2023

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial - eClinicalMedicine

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial - eClinicalMedicine

No hay comentarios:

Publicar un comentario